Suzhou Novoprotein Scientific Co., Ltd.SSE: 688137

(688137)"NOVOPROTEIN SCIENTIFIC INC."Announcement on Use of Certain Temporarily Idle Raised Funds for Cash Management

· Issued by Suzhou Novoprotein Scientific Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 688137 · · 6 pages · Chinese

Summary by 6ix AI

Suzhou Novoprotein Scientific Co., Ltd. has announced its plan to use temporarily idle raised funds for cash management purposes, aiming to enhance the efficiency of fund utilization and increase overall returns for shareholders. The company intends to invest in low-risk, liquid principal-protected products, with a maximum investment amount specified. The board has approved this plan, which does not require shareholder approval, and outlines the risk management measures in place. The investment is expected to not affect the company's normal operations or the progress of its fundraising projects.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Suzhou Novoprotein Scientific Co., Ltd. on 6ix

Story so far

Earlier from Suzhou Novoprotein Scientific

Later from Suzhou Novoprotein Scientific

All Suzhou Novoprotein Scientific news releases